Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04691297 · ClinicalTrials.gov registry record · NA
Digitally Enhanced Smoking Cessation for High Risk Smokers
A NA study of Smoking Cessation and Smoking, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 2
- Study locations
NCT04691297 is a NA study of Smoking Cessation and Smoking that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 153 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04691297, a NA study of Smoking Cessation and Smoking, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening. .
Conditions Studied
Interventions
- OTHER Standard Care
- OTHER Escape
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04691297
The ClinicalTrials.gov registry entry for NCT04691297 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (68% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.
NCT04691297 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04691297 about?
NCT04691297 is a clinical study titled "Digitally Enhanced Smoking Cessation for High Risk Smokers". This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCA...
What is the current status of trial NCT04691297?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 153 participants. The study started on 2021-02-01. Estimated completion is 2026-12-01.
What conditions does trial NCT04691297 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Smoking Behaviors, Smoking, Tobacco, Lung Cancer Screening.
What interventions are being tested in trial NCT04691297?
The interventions under investigation include: Standard Care (OTHER), Escape (OTHER).
Who is sponsoring clinical trial NCT04691297?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04691297 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.